Helixmith starts new trial of diabetic neuropathy gene therapyJust over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic Share XHelixmith starts new trial of diabetic neuropathy gene therapyhttps://pharmaphorum.com/r-d/helixmith-starts-new-trial-of-diabetic-neuropathy-gene-therapy/
Regulatory timelines in the Asia-PacificSnapshot of clinical trial application processes in the region. Share XRegulatory timelines in the Asia-Pacifichttps://pharmaphorum.com/views-and-analysis/regulatory-timelines-asia-pacific/